Brian Nowosielski

In part 3 of our interview, Jennifer Flynn, CPHRM, flips the script on potential harms in using social media and explores how pharmacists can use it to advance their career.

As patients with diabetes and other cardiometabolic conditions take control of their insulin regimens, so too are pharmacists stepping in to help manage new technologies, guidelines, and medications.

Jennifer Flynn, CPHRM, joins Drug Topics to discuss the nuances in social media use for pharmacists and the potential risks they can encounter.

In this episode, host Taylor Watterson, PharmD, PhD, welcomes Julissa Gomez, a fourth-year pharmacy student at the University of Illinois Chicago Retzky College of Pharmacy.

Spanning those focused on pneumococcal diseases to continued developments of vaccines against COVID-19, these are the most-read immunization stories from 2025.

Jennifer Flynn, CPHRM, vice president of health care risk management at the Healthcare Provider Service Organization, discusses pharmacists’ roles in patient privacy.

With brand-new challenges and opportunities in the GLP-1 space and obesity management as a whole, here are the top developments from the past year.

Marking 5 years since the COVID-19 pandemic forever changed health care in 2020, check out the top 5 COVID-19 stories from 2025.

A recent study reveals COVID-19 vaccination significantly reduces severe maternal disease and preterm birth risks during pregnancy.

In a recap of his recent NPhA continuing pharmacy education presentation, Kenric B. Ware, PharmD, MBA, AAHIVP, discussed pharmacists’ role in addressing HIV stigma.

In part 3 of our interview with Kenric B. Ware, PharmD, MBA, AAHIVP, he discusses the best approaches for addressing HIV care and prevention stigma.

The landmark oral formulation of the popular weight loss drug is set to launch in early 2026.

Kenric B. Ware, PharmD, MBA, AAHIVP, addresses the pharmacist’s role in addressing HIV stigma and providing public health services for patients with the virus.

Kenric B. Ware, PharmD, MBA, AAHIVP, presents persistently common stigmas in HIV care and prevention from a recent NPhA webinar.

With little evidence on vaccine coverage for people living with HIV, researchers explored pneumococcal vaccine rates between 2014 and 2023.

This December 2025 order is an extension of HHS’ recommendation to reconsider marijuana as a Schedule III medication in 2023.

During his second term, President Trump has bolstered his approach at lowering prescription drug prices in the US through innovative yet unprecedented decisions.

Among patients previously reporting COVID-19, researchers conduct a case-control study of REM-predominant obstructive sleep apnea.

In this episode, Natalie DiPietro Mager, PharmD, PhD, MPH, meets with Karen Kier, PhD, RPh, BCPS, BCACP, to discuss warning labels for hormonal replacement therapy.

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discussed potential safety concerns and the pharmacist’s role in managing insulin.

Ron Lanton III, Esq, provides nuance to the current state of pharmacy sustainability and how the MFN drug pricing policy could impact the industry.

During her time at ASHP Midyear 2025, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, returned to discuss all available insulin pump options.

Ron Lanton III, Esq, discusses previous MFN drug pricing policies and why the free US drug market often yields higher patient costs.

Amid a lack of research on their specific perspectives, women with epilepsy share their experiences with pregnancy and reproductive health.

Ron Lanton III, Esq, discusses the revamped version of the Trump Administration’s MFN drug pricing policy and why his second term may yield different outcomes.

Antibiotics are a prominent medication class reserved for helping patients fight bacterial infections.

Prateek Bhatia, PhD, discusses barriers to accessing infusion center services and how the pharmacist can alleviate patient challenges.

McKesson’s Ginger Thorpe discusses the gaps and opportunities in specialty pharmacy’s approach toward care coordination within health systems.

With constant vaccine and guideline updates reserved for pneumococcal diseases, pharmacists continue to be the authority on pneumococcal vaccine administration.

In an exploration of key stakeholders’ perspectives, researchers assess a lifestyle intervention for cardiometabolic health among women during or after pregnancy.